NIIMBL eXperience Program Announces 17 Students for 2021 Cohort
News provided by
Share this article
Share this article
NEWARK, Del., April 20, 2021 /PRNewswire/ The National Institute for Manufacturing Biopharmaceuticals (NIIMBL) announced 17 students selected for their 2021 NIIMBL eXperience Program. The NIIMBL eXperience is offered to African American/Black, Latinx, and Native American college freshman and sophomores students from Historically Black Colleges and Universities (HBCUs) and NIIMBL member institutions and provides real-world insight into career options in the growing biopharmaceutical industry. This year we are happy to welcome a group of students from schools ranging from Morehouse College to MIT. Each cohort is extremely unique. The students come from different backgrounds and majors, however being able to inform them of the endless opportunities in the biopharmaceutical industry significantly broadens their scope of possibilities for their field of study,
NIIMBL eXperience Program Announces 17 Students for 2021 Cohort
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
美国 拐点 与 短缺 共舞_上证指数(zssh000001)股吧_东方财富网股吧
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.
April 13, 2021
The Need for Action in Maryland; For decades, infrastructure in Maryland has suffered from a systemic lack of investment. The need for action is clear, Maryland’s infrastructure received a C grade on its Infrastructure Report Card. The American Jobs Plan will make a historic investment in our nation’s infrastructure.
ROADS AND BRIDGES: In Maryland there are 273 bridges and over 2,201 miles of highway in poor condition. Since 2011, commute times have increased by 5.1% in Maryland and on average, each driver pays $637 per year in costs due to driving on roads in need of repair. The American Jobs Plan will devote more than $600 billion to transform our nations’ transportation infrastructure and make it more resilient, including $115 billion repairing roads and bridges.
Share this article
Share this article
NEWARK, Del., April 13, 2021 /PRNewswire/ The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce that Dr. Gene Schaefer has joined the Institute as NIIMBL Senior Fellow, effective April 5, 2021. Dr. Schaefer joins NIIMBL with over 35 years of experience in the biopharmaceutical field ranging from early stage process development to commercial product support for protein therapeutics.
Dr. Gene Schaefer has joined NIIMBL as Senior Fellow.
Prior to joining NIIMBL, Dr. Schaefer was Senior Director, API Large Molecule Pharmaceutical Development & Manufacturing Sciences at Johnson & Johnson. He also led the Protein Therapeutics Development group at Bristol-Myers Squibb with additional industry experience with Schering-Plough and Genzyme.